BioNTech, VW, and Bill Ackman's IPO Pivot
Analysis of BioNTech founders' exit, Volkswagen's operational crisis and balance sheet signals, and Bill Ackman's strategic shift to listing Pershing Square. Includes macro insights on oil volatility and the dollar's safe-haven status.
BioNTech Leadership Shift and Valuation Impact
BioNTech announced the resignation of its founders, Ugur Sahin and Özlem Türeci, who are launching a new venture to focus on early-stage research. The new entity will acquire certain technologies and rights from BioNTech, with the public company receiving a minority stake and milestone payments. This move caused a 20% drop in BioNTech's stock price, as investors feared reduced founder commitment and potential dilution of innovation upside. However, the company remains financially robust with 17 billion euros in cash and a strong pipeline, including a major deal with Bristol Myers Squibb for the cancer drug BNT327. The exit highlights a strategic divergence between long-term research focus and public market expectations.
Volkswagen's Operational Crisis and Balance Sheet Signals
Volkswagen reported a 45% drop in 2025 profits, with operating margins falling below 3%. The primary driver is the rapid loss of market share in China, where VW is losing ground to local competitors. Porsche, historically a key profit center, now operates with a 0.3% margin, leading to a 2.6 billion euro goodwill write-down. While VW announced plans to cut 50,000 jobs in Germany by 2030, analysts view this as a necessary efficiency measure rather than a catastrophic failure. Notably, a decrease in latent taxes suggests management has lowered future profit expectations, yet the stock rose on a slight optimistic outlook for 2026 and a low valuation multiple.
Bill Ackman's Strategic Pivot
Bill Ackman abandoned plans for a 25 billion dollar closed-end fund IPO due to weak demand. Instead, he is listing Pershing Square USA, his asset management firm, which manages 21 billion dollars in assets with only 44 employees. The structure allows investors to buy into the fund while receiving a stake in the asset manager, which generated 760 million dollars in fees last year. This model contrasts with Warren Buffett's Berkshire Hathaway, where Ackman retains significant performance-based compensation, raising questions about alignment of interests.
Macro Volatility and Safe Havens
Oil prices experienced extreme volatility, swinging from 120 to under 90 dollars in a single day due to geopolitical tensions and speculative leverage. Despite the crisis, gold did not surge as expected, while the US dollar strengthened, reaffirming its status as a global safe haven. This contradicts early-year narratives of dollar weakness and highlights the persistent demand for USD in times of geopolitical instability. Investors are advised to avoid overreacting to daily news cycles and focus on long-term structural trends.
Key insights
-
BioNTech's founders are exiting to form a new R&D-focused company, acquiring IP from the public entity. This creates a structural conflict where the public company may lose direct access to future breakthroughs.
Impact: Investors may discount the stock due to perceived reduced innovation upside, despite strong current cash flows and pipeline.
-
Volkswagen's profit decline is driven by China market share loss and Porsche's margin collapse. The 2.6 billion euro goodwill write-down indicates significant operational distress in the luxury segment.
Impact: The stock remains undervalued relative to earnings, but the turnaround timeline is extended to 2027, increasing risk for short-term investors.
-
Bill Ackman's shift to listing his asset manager rather than a fund allows for higher fee retention and a more stable revenue stream. The high fee-to-employee ratio demonstrates operational efficiency.
Impact: This model may attract investors seeking exposure to top-tier management without the volatility of a single fund's performance.
-
Meta's acquisition of Moldbook, an AI-agent-only social network, is primarily a talent acquisition strategy. The value lies in the AI engineers rather than the platform's user base.
Impact: Big Tech companies are increasingly acquiring startups for their AI talent, signaling a shift in valuation metrics for AI-focused firms.
-
The US dollar strengthened during geopolitical crises, acting as a safe haven despite 'Sell America' narratives. Gold underperformed expectations, suggesting capital rotated to USD rather than precious metals.
Impact: Investors should maintain USD exposure as a hedge against geopolitical risk, challenging the view of the dollar's long-term decline.
Action items
-
Reassess BioNTech holdings based on the new IP transfer deal terms. Monitor the minority stake and milestone payments to the new founder-led entity to gauge potential value leakage.
Impact: Avoids overvaluing the public company if key future innovations are diverted to the private entity.
-
Analyze Volkswagen's latent tax positions and goodwill write-downs to gauge management's true internal forecasts. Use these balance sheet signals to adjust earnings expectations for 2026.
Impact: Provides a more accurate view of the turnaround timeline, reducing reliance on optimistic management commentary.
-
Evaluate Pershing Square USA's IPO structure for fee sustainability. Compare the asset manager's fee generation per employee against industry peers to assess long-term profitability.
Impact: Identifies a potentially undervalued asset management play with high operational leverage.
-
Monitor AI talent acquisition trends among Big Tech companies. Identify startups with high-value AI engineers as potential acquisition targets or investment opportunities.
Impact: Positions investors to benefit from the premium placed on specialized AI talent in the current market.
-
Maintain a diversified portfolio with USD exposure as a geopolitical hedge. Avoid overreacting to short-term oil price volatility by using long-term investment strategies rather than speculative trades.
Impact: Reduces portfolio volatility and capitalizes on the dollar's safe-haven status during crises.
Quotes
“Das Ding ist nur, so ein Medikament effizient durch die klinischen Studien zu bringen, hat eben wenig mit Forschung an neuen Medikamenten zu tun.”
“Der Markt China, der vor 5 bis 10 bis 15 Jahren noch das ganz große Goldgräberland für Volkswagen war, wo sie lange Marktführer waren, ist zurzeit ein Problemfall.”
“Don't bet against America. Deswegen dieser riesige Sell America-Trade, der da in den ersten zwei Monaten dieses Jahres beschworen wurde, war mir einfach zu viel.”